This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Hillstream BioPharma’s 8K filing here.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Further Reading
- Five stocks we like better than Hillstream BioPharma
- What Are Dividend Achievers? An Introduction
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- P/E Ratio Calculation: How to Assess Stocks
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- Basic Materials Stocks Investing
- 10 Safe Investments with High Returns
